Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites.

PubWeight™: 1.75‹?› | Rank: Top 3%

🔗 View Article (PMID 3293836)

Published in Cancer Metastasis Rev on June 01, 1988

Authors

G L Nicolson1

Author Affiliations

1: Department of Tumor Biology, University of Texas M. D. Anderson Hospital and Tumor Institute, Houston 77030.

Articles citing this

beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. Cancer Cell (2002) 5.56

AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Res (2010) 4.89

The forward rate of binding of surface-tethered reactants: effect of relative motion between two surfaces. Biophys J (1999) 2.35

The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells. Cancer Res (2005) 1.94

Stepping out of the flow: capillary extravasation in cancer metastasis. Clin Exp Metastasis (2007) 1.68

Technical considerations for studying cancer metastasis in vivo. Clin Exp Metastasis (1997) 1.62

Rolling and adhesion of human tumor cells on vascular endothelium under physiological flow conditions. J Clin Invest (1993) 1.56

Significance of heparanase in cancer and inflammation. Cancer Microenviron (2011) 1.46

Effect of microvillus deformability on leukocyte adhesion explored using adhesive dynamics simulations. Biophys J (2005) 1.46

Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier. Nat Commun (2015) 1.37

Independence of metastatic ability and extravasation: metastatic ras-transformed and control fibroblasts extravasate equally well. Proc Natl Acad Sci U S A (1996) 1.25

Separable growth and migration factors for large-cell lymphoma cells secreted by microvascular endothelial cells derived from target organs for metastasis. Br J Cancer (1992) 1.21

Interleukin 6: a fibroblast-derived growth inhibitor of human melanoma cells from early but not advanced stages of tumor progression. Proc Natl Acad Sci U S A (1992) 1.20

Cell biology of liver endothelial and Kupffer cells. Gut (1994) 1.19

Metastasis suppressor genes at the interface between the environment and tumor cell growth. Int Rev Cell Mol Biol (2011) 1.18

RANKL-induced CCL22/macrophage-derived chemokine produced from osteoclasts potentially promotes the bone metastasis of lung cancer expressing its receptor CCR4. Clin Exp Metastasis (2006) 1.17

Fascin is a key regulator of breast cancer invasion that acts via the modification of metastasis-associated molecules. PLoS One (2011) 1.10

Cell surface molecules and their prognostic values in assessing colorectal carcinomas. Ann Surg (2000) 1.08

Metastasis suppressors and the tumor microenvironment. Cancer Microenviron (2008) 1.07

The tumor microenvironment: the making of a paradigm. Cancer Microenviron (2009) 1.06

Altered melanoma cell surface glycosylation mediates organ specific adhesion and metastasis via lectin receptors on the lung vascular endothelium. Clin Exp Metastasis (2005) 1.03

Metastasis suppressors and the tumor microenvironment. Semin Cancer Biol (2010) 1.03

Decoding melanoma metastasis. Cancers (Basel) (2010) 1.02

CCL25 mediates migration, invasion and matrix metalloproteinase expression by breast cancer cells in a CCR9-dependent fashion. Int J Oncol (2011) 1.01

Significance of VLA-4-VCAM-1 interaction and CD44 for transendothelial invasion in a bone marrow metastatic myeloma model. Clin Exp Metastasis (1999) 1.00

Different adhesion properties of highly and poorly metastatic HT-29 colon carcinoma cells with extracellular matrix components: role of integrin expression and cytoskeletal components. Br J Cancer (1999) 0.99

The role of microenvironment in tumor angiogenesis. Genes Nutr (2008) 0.98

Betulinic acid augments the inhibitory effects of vincristine on growth and lung metastasis of B16F10 melanoma cells in mice. Br J Cancer (2004) 0.98

Mast cell modulation of tumour cell proliferation in rat mammary adenocarcinoma 13762NF. Br J Cancer (1991) 0.97

Beta1-integrin-mediated dynamic adhesion of colon carcinoma cells to extracellular matrix under laminar flow. Clin Exp Metastasis (1999) 0.96

In vivo evaluation of the early events associated with liver metastasis of circulating cancer cells. Br J Cancer (2001) 0.96

Milky spots promote ovarian cancer metastatic colonization of peritoneal adipose in experimental models. Am J Pathol (2013) 0.95

Integrin α2β1 mediates tyrosine phosphorylation of vascular endothelial cadherin induced by invasive breast cancer cells. J Biol Chem (2012) 0.94

The connectivity of lymphogenous and hematogenous tumor cell dissemination: biological insights and clinical implications. Clin Exp Metastasis (2012) 0.93

Versatile roles of extracellular vesicles in cancer. J Clin Invest (2016) 0.92

Differential microstructure and physiology of brain and bone metastases in a rat breast cancer model by diffusion and dynamic contrast enhanced MRI. Clin Exp Metastasis (2011) 0.92

Expression level of integrin alpha 5 on tumour cells affects the rate of metastasis to the kidney. Br J Cancer (2003) 0.89

Carcinoembryonic antigen (CEA) and its receptor hnRNP M are mediators of metastasis and the inflammatory response in the liver. Clin Exp Metastasis (2011) 0.88

The presence of scatter factor in patients with metastatic spread to the pleura. Br J Cancer (1992) 0.87

Role of the cytoskeleton in adhesion stabilization of human colorectal carcinoma cells to extracellular matrix components under dynamic conditions of laminar flow. Clin Exp Metastasis (1999) 0.86

The effect of proteoglycans inhibited by RNA interference on metastatic characters of human salivary adenoid cystic carcinoma. BMC Cancer (2009) 0.85

Tumor cell surface beta 1-4-linked galactose binds to lectin(s) on microvascular endothelial cells and contributes to organ colonization. J Cell Biol (1990) 0.84

Galectin-3 expressed on different lung compartments promotes organ specific metastasis by facilitating arrest, extravasation and organ colonization via high affinity ligands on melanoma cells. Clin Exp Metastasis (2014) 0.84

In vitro experimental studies of sialyl Lewis x and sialyl Lewis a on endothelial and carcinoma cells: crucial glycans on selectin ligands. Glycoconj J (1997) 0.83

Human colon cancer cells deficient in DCC produce abnormal transcripts in progression of carcinogenesis. Dig Dis Sci (2001) 0.82

Poly N-acetyllactosamine substitutions on N- and not O-oligosaccharides or Thomsen-Friedenreich antigen facilitate lung specific metastasis of melanoma cells via galectin-3. Glycoconj J (2008) 0.82

Integrin alpha4beta1/VCAM-1 pathway mediates primary adhesion of RAW117 lymphoma cells to hepatic sinusoidal endothelial cells under flow. Clin Exp Metastasis (1999) 0.82

Clonal expansion analysis of transposon insertions by high-throughput sequencing identifies candidate cancer genes in a PiggyBac mutagenesis screen. PLoS One (2013) 0.82

Prostate cancer cells show elevated urokinase receptor in a mouse model of metastasis. Cancer Cell Int (2006) 0.82

Bone marrow metastatic myeloma cells promote osteoclastogenesis through RANKL on endothelial cells. Clin Exp Metastasis (2003) 0.80

Chance mechanisms affecting the burden of metastases. BMC Cancer (2005) 0.80

Cathepsin B and other proteases in human colorectal carcinoma. Am J Pathol (1994) 0.80

Low E-cadherin and beta-catenin expression correlates with increased spontaneous and artificial lung metastases of murine carcinomas. Clin Exp Metastasis (1999) 0.79

Decoding the Secret of Cancer by Means of Extracellular Vesicles. J Clin Med (2016) 0.79

Expression of sarcosine metabolism-related proteins according to metastatic site in breast cancer. Int J Clin Exp Pathol (2014) 0.78

Differential adhesion of metastatic RAW117 large-cell lymphoma cells under static or hydrodynamic conditions: role of integrin alpha(v) beta3. Clin Exp Metastasis (1997) 0.78

Integrin expression and ability to adhere to extracellular matrix proteins and endothelial cells in human lung cancer lines. Br J Cancer (1994) 0.78

Expression of Yes-associated protein (YAP) in metastatic breast cancer. Int J Clin Exp Pathol (2015) 0.78

Is the Fischer 344/CRJ rat a protein-knock-out model for dipeptidyl peptidase IV-mediated lung metastasis of breast cancer? Clin Exp Metastasis (1999) 0.78

Prostate cancer and bone: the elective affinities. Biomed Res Int (2014) 0.78

Expression of cancer-associated fibroblast related proteins in metastatic breast cancer: an immunohistochemical analysis. J Transl Med (2015) 0.77

Decreased adhesion to endothelial cells and matrix proteins of H-2Kb gene transfected tumour cells. Br J Cancer (1993) 0.77

Site-specific metabolic phenotypes in metastatic breast cancer. J Transl Med (2014) 0.77

Rupture of multiple catch-slip bonds: Two-state two-pathway catch-slip bonds. Eur Phys J E Soft Matter (2013) 0.76

A theoretical method to determine unstressed off-rate from multiple bond force spectroscopy. Colloids Surf B Biointerfaces (2012) 0.75

Effect of viscous drag on multiple receptor-ligand bonds rupture force. Colloids Surf B Biointerfaces (2012) 0.75

Cancer and the metastatic substrate. Ecancermedicalscience (2016) 0.75

Inhibiting interleukin-19 activity ameliorates esophageal squamous cell carcinoma progression. PLoS One (2013) 0.75

Influence of host microvascular environment on tumour vascular endothelium. Int J Exp Pathol (1999) 0.75

Rupture of single receptor-ligand bonds: a new insight into probability distribution function. Colloids Surf B Biointerfaces (2012) 0.75

Differential Site-Based Expression of Pentose Phosphate Pathway-Related Proteins among Breast Cancer Metastases. Dis Markers (2017) 0.75

Occurrence of cancer at multiple sites: towards distinguishing multigenesis from metastasis. Biol Direct (2008) 0.75

Rupture of multiple receptor-ligand bonds: bimodal distribution of bond rupture force. Eur Phys J E Soft Matter (2012) 0.75

A unique allogenic model of metastatic pheochromocytoma: PC12 rat pheochromocytoma xenografts to nude mice and establishment of metastases-derived PC12 variants. Clin Exp Metastasis (1998) 0.75

Timeline metastatic progression: in the wake of the « seed and soil » theory. Med Oncol (2017) 0.75